(AOF) – The listed French company Hybrigenics today announces its repositioning under the name Aton, marking the completion of the transformation begun two years ago. The company’s new visual identity and rebranding aims to position it as a leading player in the pharmaceutical and biotechnology industry. The doubling of Aton’s workforce planned over the next two years “will strengthen its capabilities and accelerate research and development efforts”.
A French company created in 1998, Aton is made up of four entities: “Bcell Design”, a specialist in premium quality antibodies for the in vitro diagnostic (IVD), research and development of therapeutic products sectors; “Inoviem Scientific” which supports biotech companies by accelerating and securing the entire development process of their drugs; “Pims Technology” which “develops an analysis instrument designed to personalize treatments, ensuring that they are adapted to the needs of patients”, and “Stemcis” which “manufactures surgical kits intended for lipofilling”.
© 2023 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
